anmelden
Analysen von Richard Vosser
| 11.02.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.20 | Roche overweight | JP Morgan Chase & Co. | |
| 30.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 29.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 27.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 27.01.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 07.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 06.01.20 | MorphoSys overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 06.01.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Sanofi overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 06.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 02.01.20 | Roche overweight | JP Morgan Chase & Co. | |
| 25.11.19 | Roche overweight | JP Morgan Chase & Co. | |
| 21.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 04.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 01.11.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 21.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 17.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 11.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 02.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 30.09.19 | Roche overweight | JP Morgan Chase & Co. | |
| 23.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 20.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.09.19 | Roche overweight | JP Morgan Chase & Co. | |
| 13.09.19 | Roche overweight | JP Morgan Chase & Co. | |
| 12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.09.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.08.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.08.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 29.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 19.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 18.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 16.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 15.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 01.07.19 | Roche overweight | JP Morgan Chase & Co. | |
| 28.06.19 | Roche overweight | JP Morgan Chase & Co. | |
